CELZ Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Creative Medical Technology

The quarterly EPS trajectory demonstrates profit dynamics, with the figure recorded at 16.60. Creative Medical Technology (CELZ) management aims to commercialize patents in the fields of diabetes therapy and erectile dysfunction. The company is currently scaling its cellular platform through clinical trials in the US. Success is driven by a tight-knit environment of top researchers motivated by stock option programs and a high degree of autonomy.

creativemedicaltechnology.com (CELZ) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan saka 04.07.2022 nganti 10.11.2026

Creative Medical Technology - rincian analitis lan metrik utama (CELZ)

- rega saham lan prakiraan rega para ahli:

Rega saham creativemedicaltechnology.com|CELZ - Target konsensus

- data kapitalisasi pasar:

Nilai pasar Creative Medical Technology Holdings Inc.|CELZ - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Nilai Buku saben Saham Creative Medical Technology|CELZ - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku creativemedicaltechnology.com|CELZ - Total Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Rasio Total Utang marang Ekuitas Creative Medical Technology|CELZ - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal creativemedicaltechnology.com|CELZ - Gunggung kewajiban utang perusahaan|Utang marang nilai buku Creative Medical Technology Holdings Inc.|CELZ - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Creative Medical Technology|Indikator likuiditas cepet creativemedicaltechnology.com

- indikator bathi lan kelipatan valuasi:

CELZ - Bathi pungkasan|Bathi sing dikarepake Creative Medical Technology|CELZ - Koefisien rega marang bathi|Pangali Forward P/E creativemedicaltechnology.com|CELZ - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA Creative Medical Technology Holdings Inc.|CELZ - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Creative Medical Technology|CELZ - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan creativemedicaltechnology.com|CELZ - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Creative Medical Technology

Analisis kabeh metrik perusahaan:Creative Medical Technology Holdings, Inc., CELZ

The competitiveness of Creative Medical Technology (CELZ) is based on innovations in regenerative medicine and patents for the treatment of diabetes and erectile dysfunction. Quantifying this progress through quarterly growth in net income per share reveals the actual effectiveness of clinical trial commercialization, while shifts in quarterly EPS dynamics signal emerging trends or the risk of stagnation even amidst apparent price stability.

Pesaing langsung

MESO: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Lineage Cell Therapeutics Inc|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Surrozen Corp|CCEL: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan FBLG|LGVN - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan BRTX (BioRestorative Therapies, Inc.)